Global Infection Prevention and Enteral Access Market Research Report 2019

Table of Contents

Executive Summary

1 Infection Prevention and Enteral Access Market Overview

• 1.1 Product Overview and Scope of Infection Prevention and Enteral Access
• 1.2 Infection Prevention and Enteral Access Segment by Type
  • 1.2.1 Global Infection Prevention and Enteral Access Production Growth Rate Comparison by Type (2014-2025)
  • 1.2.2 Enteral Feeding Pumps
  • 1.2.3 Enteral Feeding Tubes
  • 1.2.4 Administration Reservoirs
  • 1.2.5 Giving Sets
  • 1.2.6 Enteral Syringes
• 1.3 Infection Prevention and Enteral Access Segment by Application
  • 1.3.1 Infection Prevention and Enteral Access Consumption Comparison by Application (2014-2025)
  • 1.3.2 Oncology
  • 1.3.3 Gastroenterology
  • 1.3.4 Diabetes
  • 1.3.5 Neurological Disorders
  • 1.3.6 Hypermetabolism
  • 1.3.7 Others
• 1.4 Global Infection Prevention and Enteral Access Market by Region
  • 1.4.1 Global Infection Prevention and Enteral Access Market Size Region
  • 1.4.2 North America Status and Prospect (2014-2025)
  • 1.4.3 Europe Status and Prospect (2014-2025)
  • 1.4.4 China Status and Prospect (2014-2025)
  • 1.4.5 Japan Status and Prospect (2014-2025)
• 1.5 Global Infection Prevention and Enteral Access Market Size
  • 1.5.1 Global Infection Prevention and Enteral Access Revenue (2014-2025)
  • 1.5.2 Global Infection Prevention and Enteral Access Production (2014-2025)

2 Global Infection Prevention and Enteral Access Market Competition by Manufacturers

• 2.1 Global Infection Prevention and Enteral Access Production Market Share by Manufacturers (2014-2019)
• 2.2 Global Infection Prevention and Enteral Access Revenue Share by Manufacturers (2014-2019)
• 2.3 Global Infection Prevention and Enteral Access Average Price by Manufacturers (2014-2019)
• 2.4 Manufacturers Infection Prevention and Enteral Access Production Sites, Area Served, Product Types
• 2.5 Infection Prevention and Enteral Access Market Competitive Situation and Trends
  • 2.5.1 Infection Prevention and Enteral Access Market Concentration Rate
  • 2.5.2 Infection Prevention and Enteral Access Market Share of Top 3 and Top 5 Manufacturers
  • 2.5.3 Mergers & Acquisitions, Expansion

3 Global Infection Prevention and Enteral Access Production Market Share by Regions

• 3.1 Global Infection Prevention and Enteral Access Production Market Share by Regions
• 3.2 Global Infection Prevention and Enteral Access Revenue Market Share by Regions (2014-2019)
• 3.3 Global Infection Prevention and Enteral Access Production, Revenue, Price and Gross Margin (2014-2019)
• 3.4 North America Infection Prevention and Enteral Access Production
  • 3.4.1 North America Infection Prevention and Enteral Access Production Growth Rate (2014-2019)
  • 3.4.2 North America Infection Prevention and Enteral Access Production, Revenue, Price and Gross Margin (2014-2019)
• 3.5 Europe Infection Prevention and Enteral Access Production
  • 3.5.1 Europe Infection Prevention and Enteral Access Production Growth Rate (2014-2019)
  • 3.5.2 Europe Infection Prevention and Enteral Access Production, Revenue, Price and Gross Margin (2014-2019)
• 3.6 China Infection Prevention and Enteral Access Production (2014-2019)
  • 3.6.1 China Infection Prevention and Enteral Access Production Growth Rate (2014-2019)
  • 3.6.2 China Infection Prevention and Enteral Access Production, Revenue, Price and Gross Margin (2014-2019)
• 3.7 Japan Infection Prevention and Enteral Access Production (2014-2019)
  • 3.7.1 Japan Infection Prevention and Enteral Access Production Growth Rate (2014-2019)
  • 3.7.2 Japan Infection Prevention and Enteral Access Production, Revenue, Price and Gross Margin (2014-2019)

4 Global Infection Prevention and Enteral Access Consumption by Regions

• 4.1 Global Infection Prevention and Enteral Access Consumption by Regions
• 4.2 North America Infection Prevention and Enteral Access Consumption (2014-2019)
• 4.3 Europe Infection Prevention and Enteral Access Consumption (2014-2019)
• 4.4 China Infection Prevention and Enteral Access Consumption (2014-2019)
• 4.5 Japan Infection Prevention and Enteral Access Consumption (2014-2019)

5 Global Infection Prevention and Enteral Access Production, Revenue, Price Trend by Type

• 5.1 Global Infection Prevention and Enteral Access Production Market Share by Type (2014-2019)
• 5.2 Global Infection Prevention and Enteral Access Revenue Market Share by Type (2014-2019)
• 5.3 Global Infection Prevention and Enteral Access Price by Type (2014-2019)
• 5.4 Global Infection Prevention and Enteral Access Production Growth by Type (2014-2019)

6 Global Infection Prevention and Enteral Access Market Analysis by Applications

• 6.1 Global Infection Prevention and Enteral Access Consumption Market Share by Application (2014-2019)
• 6.2 Global Infection Prevention and Enteral Access Consumption Growth Rate by Application (2014-2019)

7 Company Profiles and Key Figures in Infection Prevention and Enteral Access Business

• 7.1 Cook Medical
  • 7.1.1 Cook Medical Infection Prevention and Enteral Access Production Sites and Area Served
  • 7.1.2 Infection Prevention and Enteral Access Product Introduction, Application and Specification
  • 7.1.3 Cook Medical Infection Prevention and Enteral Access Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.1.4 Main Business and Markets Served
• 7.2 Medtronic plc
  • 7.2.1 Medtronic plc Infection Prevention and Enteral Access Production Sites and Area Served
  • 7.2.2 Infection Prevention and Enteral Access Product Introduction, Application and Specification
  • 7.2.3 Medtronic plc Infection Prevention and Enteral Access Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.2.4 Main Business and Markets Served
• 7.3 Boston Scientific Corporation
  • 7.3.1 Boston Scientific Corporation Infection Prevention and Enteral Access Production Sites and Area Served
  • 7.3.2 Infection Prevention and Enteral Access Product Introduction, Application and Specification
  • 7.3.3 Boston Scientific Corporation Infection Prevention and Enteral Access Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.3.4 Main Business and Markets Served
• 7.4 CONMED Corporation
  • 7.4.1 CONMED Corporation Infection Prevention and Enteral Access Production Sites and Area Served
  • 7.4.2 Infection Prevention and Enteral Access Product Introduction, Application and Specification
  • 7.4.3 CONMED Corporation Infection Prevention and Enteral Access Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.4.4 Main Business and Markets Served
• 7.5 CORPAK MedSystems
  • 7.5.1 CORPAK MedSystems Infection Prevention and Enteral Access Production Sites and Area Served
  • 7.5.2 Infection Prevention and Enteral Access Product Introduction, Application and Specification
  • 7.5.3 CORPAK MedSystems Infection Prevention and Enteral Access Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.5.4 Main Business and Markets Served
• 7.6 CR Bard
  • 7.6.1 CR Bard Infection Prevention and Enteral Access Production Sites and Area Served
  • 7.6.2 Infection Prevention and Enteral Access Product Introduction, Application and Specification
  • 7.6.3 CR Bard Infection Prevention and Enteral Access Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.6.4 Main Business and Markets Served
• 7.7 ALCOR Scientific
  • 7.7.1 ALCOR Scientific Infection Prevention and Enteral Access Production Sites and Area Served
  • 7.7.2 Infection Prevention and Enteral Access Product Introduction, Application and Specification
  • 7.7.3 ALCOR Scientific Infection Prevention and Enteral Access Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.7.4 Main Business and Markets Served
• 7.8 Pacific Hospital Supply
  • 7.8.1 Pacific Hospital Supply Infection Prevention and Enteral Access Production Sites and Area Served
  • 7.8.2 Infection Prevention and Enteral Access Product Introduction, Application and Specification
  • 7.8.3 Pacific Hospital Supply Infection Prevention and Enteral Access Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.8.4 Main Business and Markets Served
• 7.9 Teleflexorporated
  • 7.9.1 Teleflexorporated Infection Prevention and Enteral Access Production Sites and Area Served
  • 7.9.2 Infection Prevention and Enteral Access Product Introduction, Application and Specification
  • 7.9.3 Teleflexorporated Infection Prevention and Enteral Access Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.9.4 Main Business and Markets Served
• 7.10 Vygon SA
  • 7.10.1 Vygon SA Infection Prevention and Enteral Access Production Sites and Area Served
  • 7.10.2 Infection Prevention and Enteral Access Product Introduction, Application and Specification
  • 7.10.3 Vygon SA Infection Prevention and Enteral Access Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.10.4 Main Business and Markets Served

8 Infection Prevention and Enteral Access Manufacturing Cost Analysis

• 8.1 Infection Prevention and Enteral Access Key Raw Materials Analysis
  • 8.1.1 Key Raw Materials
  • 8.1.2 Price Trend of Key Raw Materials
  • 8.1.3 Key Suppliers of Raw Materials
• 8.2 Proportion of Manufacturing Cost Structure
• 8.3 Manufacturing Process Analysis of Infection Prevention and Enteral Access
• 8.4 Infection Prevention and Enteral Access Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers

• 9.1 Marketing Channel
  • 9.1.1 Direct Marketing
  • 9.1.2 Indirect Marketing
• 9.2 Infection Prevention and Enteral Access Distributors List
• 9.3 Infection Prevention and Enteral Access Customers

10 Market Dynamics

• 10.1 Market Trends
• 10.2 Opportunities
• 10.3 Market Drivers
• 10.4 Challenges
• 10.5 Influence Factors

11 Global Infection Prevention and Enteral Access Market Forecast

• 11.1 Global Infection Prevention and Enteral Access Production, Revenue Forecast
  • 11.1.1 Global Infection Prevention and Enteral Access Production Growth Rate Forecast (2019-2025)
  • 11.1.2 Global Infection Prevention and Enteral Access Revenue and Growth Rate Forecast (2019-2025)
  • 11.1.3 Global Infection Prevention and Enteral Access Price and Trend Forecast (2019-2025)
• 11.2 Global Infection Prevention and Enteral Access Production Forecast by Regions (2019-2025)
  • 11.2.1 North America Infection Prevention and Enteral Access Production, Revenue Forecast (2019-2025)
  • 11.2.2 Europe Infection Prevention and Enteral Access Production, Revenue Forecast (2019-2025)
  • 11.2.3 China Infection Prevention and Enteral Access Production, Revenue Forecast (2019-2025)
  • 11.2.4 Japan Infection Prevention and Enteral Access Production, Revenue Forecast (2019-2025)
• 11.3 Global Infection Prevention and Enteral Access Consumption Forecast by Regions (2019-2025)
  • 11.3.1 North America Infection Prevention and Enteral Access Consumption Forecast (2019-2025)
  • 11.3.2 Europe Infection Prevention and Enteral Access Consumption Forecast (2019-2025)
  • 11.3.3 China Infection Prevention and Enteral Access Consumption Forecast (2019-2025)
  • 11.3.4 Japan Infection Prevention and Enteral Access Consumption Forecast (2019-2025)
• 11.4 Global Infection Prevention and Enteral Access Production, Revenue and Price Forecast by Type (2019-2025)
• 11.5 Global Infection Prevention and Enteral Access Consumption Forecast by Application (2019-2025)

12 Research Findings and Conclusion

13 Methodology and Data Source

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List